Ameritas Investment Partners’s Trillium Therapeutics Inc. TRIL Stock Holding History

Ameritas Investment Partners’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-7,670	Closed	-$135K	–	3138
2021 Q3	$135K	Hold	7,670	–	–	﹤0.01%	1506
2021 Q2	$74K	Buy	+7,670	New	+$72.2K	﹤0.01%	1923

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Ameritas Investment Partners's TRIL Position: Q4 2021 in Review

Ameritas Investment Partners sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 7,670 shares — an estimated $135K sold.

Ameritas Investment Partners first reported a position in TRIL in Q2 2021 and held it in 2 quarters. The position peaked at $135K in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

Ameritas Investment Partners reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
Ameritas Investment Partners sold 7,670 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $135K.
Ameritas Investment Partners first reported a position in Trillium Therapeutics Inc. in Q2 2021 and held it in 2 quarters.
Ameritas Investment Partners's Trillium Therapeutics Inc. position peaked at $135K in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on Ameritas Investment Partners's 13F filing for Q4 2021, filed 11 Feb 2022.